Care and treatment

Resource
September 29, 2016

Although the risk of human papillomavirus (HPV) infection is greatest in young women, women older than 25 years remain at risk. We present data from the VIVIANE study of the HPV 16/18 AS04-adjuvanted vaccine in adult women after 7 years of follow-up.

Resource
September 29, 2016

IPM's 2015 annual report looks at promising new technologies in IPM's pipeline that could put the power of HIV prevention in women's hands.

Resource
September 29, 2016

A very low viral load (20-49 copies/ml) during HIV therapy does not increase the risk of the subsequent virological failure of treatment (viral load above 200 copies/ml), according to Spanish research published in HIV Medicine. The findings of the study will provide reassurance that peop

Resource
September 26, 2016

Depression is highly prevalent in people with HIV and has consistently been associated with poor antiretroviral therapy (ART) adherence. Integrating cognitive behavioural therapy (CBT) for depression with adherence counselling using the Life-Steps approach (CBT-AD) has an emerging evidence base.

Resource
September 26, 2016

Background: A fraction of HIV-diagnosed individuals promptly initiate antiretroviral therapy (ART).

Resource
September 23, 2016

The scale-up of antiretroviral therapy (ART) in Malawi was based on a public health approach adapted to its resource-poor setting, with principles and practices borrowed from the successful tuberculosis control framework.

Resource
September 23, 2016

Tuberculosis (TB) case notification rates are usually higher in men than in women, but notification data are insufficient to measure sex differences in disease burden.

Resource
September 21, 2016

For the treatment of HIV, compliance in regard to appointment attendance and medication usage is critical. Various methods have been attempted to increased HIV care compliance, and a method that has inspired many published studies is text message reminders.

Resource
September 21, 2016

Little is known about the effect of community versus health facility-based interventions to improve and sustain antiretroviral therapy (ART) adherence, virologic suppression, and retention in care among HIV-infected individuals in low- and middle-income countries (LMICs).